Marion Dorsch, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 4,600 shares at $79.00 ($363K) on 2019-12-19, disclosed to the SEC on 2019-12-23.
Open-market sale of $363k BPMC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BPMC | SELL | 2020-10-08 | $455K | — | Filing → |
| BPMC | SELL | 2020-09-25 | $409K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $363K | — | Filing → |